financetom
Business
financetom
/
Business
/
Buckle Says Comparable Store Sales Rose 3.8% in June
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Buckle Says Comparable Store Sales Rose 3.8% in June
Jul 10, 2025 4:50 AM

07:22 AM EDT, 07/10/2025 (MT Newswires) -- Buckle (BKE) said Thursday that comparable store net sales for the five-week period ending July 5 rose 3.8% from the same period a year earlier.

Net sales for the five-week fiscal month rose 4.7% to $106.5 million from $101.7 million a year earlier, the company said.

For the 22-week period ending July 5, comparable store net sales increased 3.9% year-over-year, the company said.

Net sales for the period rose 4.7% to $467.0 million from $446.2 million a year ago.

Comparable store sales reflect performance at stores open at least one year, the company said.

Buckle shares were 0.5% higher in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
Dec 20, 2024
By Bhanvi Satija Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's ( LLY ) weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder. The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the...
House Democrat says Republicans protecting Elon Musk's Chinese investments
House Democrat says Republicans protecting Elon Musk's Chinese investments
Dec 20, 2024
WASHINGTON (Reuters) - The top Democrat on the House of Representatives Appropriations Committee said on Friday that Republicans in Congress were protecting Elon Musk's Chinese investments by scrapping provisions restricting U.S. investments. Representative Rosa DeLauro said in a letter that Musk, the CEO of electric car maker Tesla, may have upended the government funding process to remove a provision that...
Centessa Pharmaceuticals Insider Sold Shares Worth $959,057, According to a Recent SEC Filing
Centessa Pharmaceuticals Insider Sold Shares Worth $959,057, According to a Recent SEC Filing
Dec 20, 2024
05:27 PM EST, 12/20/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on December 20, 2024, sold 55,000 shares in Centessa Pharmaceuticals ( CNTA ) for $959,057. Following the Form 4 filing with the SEC, Saha has control over a total of 558,661 shares of the company, with 520,661 shares held directly and 38,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1847903/000184790324000186/xslF345X05/wk-form4_1734733345.xml...
Hippo Holdings Insider Sold Shares Worth $310,958, According to a Recent SEC Filing
Hippo Holdings Insider Sold Shares Worth $310,958, According to a Recent SEC Filing
Dec 20, 2024
05:32 PM EST, 12/20/2024 (MT Newswires) -- Stewart Ellis, CFO, Chief Strategy Officer, on December 18, 2024, sold 12,000 shares in Hippo Holdings ( HIPO ) for $310,958. Following the Form 4 filing with the SEC, Ellis has control over a total of 338,550 shares of the company, with 328,215 shares held directly and 10,335 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1828105/000156218024008542/xslF345X05/primarydocument.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved